ART6043 for neoplasm metastasis

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 12 Jun 2023: Trial registered, NCT05898399
  2. 30 Jun 2023: Trial started, NCT05898399

The trials

NCT05898399: Study of ART6043 in Advanced/Metastatic Solid Tumors Patients (POLKA)

State
Under way
Phase
Phase 1 and Phase 2
People
181 planned
Started
30 Jun 2023
Primary completion
30 Jun 2028
Arms
Part A1 (ART6043 as monotherapy)
Results
None posted
  1. 12 Jun 2023: Trial registered
  2. 30 Jun 2023: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.